Discovery of pyridomycin derivatives as InhA inhibitors from actinomycetes through molecular networking and an In-House tandem mass library
摘要
A screen of ~ 4000 actinomycetes strains identified Streptomyces sp. W3009 as a producer of the antituberculosis agent pyridomycin. Using a mass spectrometry-based metabolomics approach coupled with molecular networking, we identified seven pyridomycin derivatives, six of which were novel. Three of these novel compounds were linear, featuring a unique 3-hydroxypicolinic acid–l-threonine–3-(3-pyridyl)-l-alanine (3HP–T–3PA) scaffold. Their structures were elucidated via detailed NMR studies. While two cyclic derivatives (4 and 5) showed modest antitubercular activity, the three linear derivatives, despite possessing the key 3HP–T–3PA moiety, exhibited no inhibitory activity. This intensive MS-based approach demonstrates the important role of such techniques in the discovery of novel biologically active core structures and their natural derivatives.
Graphical Abstract